09.12.2012 Views

Table of Contents - WOC 2012

Table of Contents - WOC 2012

Table of Contents - WOC 2012

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>WOC</strong><strong>2012</strong> Abstract Book<br />

PO-ONC-10<br />

Clinical Features <strong>of</strong> Retinocytoma: A Case series<br />

Chawla Bhavna (1) , Jain Amit (1)<br />

1. All India Institute <strong>of</strong> Medical Sciences<br />

Objective: To report the clinical features <strong>of</strong> retinocytoma, a benign variant <strong>of</strong><br />

retinoblastoma (Rb).<br />

Methods: Retinocytoma was diagnosed as an incidental finding in 3 cases who<br />

presented to our centre between 2010-2011<br />

Results: In Case 1 (27 yrs, F) and Case 2 (30 yrs, F), the tumor was detected<br />

on parental screening, as both cases presented with a child affected<br />

with bilateral Rb. Case 3 was a 7 yr old male with a history <strong>of</strong> enucleation<br />

elsewhere for Rb, and the retinocytoma was discovered in the other eye on<br />

routine examination. The right eye was affected in all cases and the tumor was<br />

extramacular in location. Visual acuity in the affected eye was 6/9 in Case 1 &<br />

3, and 2/60 in Case 2. Ophthalmoscopic features included translucent retinal<br />

mass, chorioretinal atrophy, and calcification. Co-existent irid<strong>of</strong>undal coloboma<br />

was noted in Case 2. Transpupillary Thermotherapy was performed in Case 3.<br />

Conclusion: Though a rare tumor, awareness regarding clinical features and<br />

natural history <strong>of</strong> retinocytoma and its differentiation from Rb is important.<br />

Meticulous follow-up is warranted in a case <strong>of</strong> retinocytoma, as it may rarely<br />

undergo malignant transformation<br />

PO-ONC-11<br />

Role <strong>of</strong> 18-F Fluorodeoxyglucose Positron Emission Tomography/<br />

Computed Tomography (PET/CT) scan in choroidal melanoma: a<br />

pilot study on Indian eyes<br />

Chawla Bhavna (1) , Kumar Rakesh (1) , Gupta Anoop (1) , Sahoo Manas (1) , Sen<br />

Seema (1)<br />

1. All India Institute <strong>of</strong> Medical Sciences<br />

Purpose: To evaluate the role <strong>of</strong> 18- F fluorodeoxyglucose (FDG) Positron<br />

Emission Tomography/Computed Tomography (PET/CT) in cases <strong>of</strong> advanced<br />

choroidal melanoma<br />

Methods: Patients with a clinical diagnosis <strong>of</strong> advanced choroidal melanoma<br />

who presented to our center between 2009-2011 underwent 18F-FDG PET/<br />

CT scan prior to enucleation for the detection <strong>of</strong> primary tumor as well as<br />

distant metastasis. Intravenous injection <strong>of</strong> radiotracer 370 MBq <strong>of</strong> 18F-FDG<br />

was given and 60 minutes later, PET-CT images were acquired in a craniocaudal<br />

fashion on a PET/CT scanner. Results <strong>of</strong> imaging were analysed by two<br />

experienced nuclear medicine physicians.<br />

Results: Twenty patients (13 males, 7 females) were evaluated. All cases<br />

(100%) showed abnormal tracer uptake in the choroidal region <strong>of</strong> the eye.<br />

Although routine metastatic work-up was within normal limits in all cases, 2<br />

patients (10%) had abnormal radiotracer uptake in distant locations on PET/<br />

CT scan.<br />

Conclusion: PET/CT scan is emerging as an invaluable imaging modality in<br />

patients with choroidal melanoma, as a single test which can be used for the<br />

detection and localization <strong>of</strong> primary tumor as well as for metastatic disease.<br />

570<br />

PO-ONC-12<br />

Single Nucleotide Polymorphism (SNP) based pyrosequencing for<br />

detection <strong>of</strong> chromosome 3 monosomy on fine needle aspiration<br />

biopsies (FNABs) <strong>of</strong> uveal melanoma patients<br />

Einbock Wilma (1) , Siebolts Udo (2) , Wiedemann Peter (1) , Wickenhauser C. (2) ,<br />

Wittekind Christian (2)<br />

1. University Hospital <strong>of</strong> Leipzig, Department <strong>of</strong> Ophthalmology<br />

2. University Hospital <strong>of</strong> Leipzig, Institute <strong>of</strong> Pathology<br />

Purpose: About 50% <strong>of</strong> uveal melanoma carry chromosome 3 monosomy,<br />

which has been shown to be a significant predictor <strong>of</strong> metastatic disease and<br />

poor prognosis.<br />

Methods: From 15 uveal melanoma patients H&E staining was performed on<br />

FNA smears for determination <strong>of</strong> melanoma subtype. DNA was extracted from<br />

the smears and from blood <strong>of</strong> the respective patients. Blood DNA was screened<br />

for informative because heterozygous SNP loci on chromosome 3 performing<br />

pyrosequencing. Accordingly, data were compared with those obtained by<br />

tumour DNA analysis. In case <strong>of</strong> pseudo-homozygous conversion <strong>of</strong> the tested<br />

SNP, allele-loss and therefore monosomy was stated. Results were verified by<br />

fluorescence in situ hybridisation (FISH) on smears and corresponding tissue<br />

probes. In addition, pyrosequencing was performed on histomorphologic<br />

evaluated, macro dissected tumour tissues <strong>of</strong> the enucleated eyes.<br />

Results: In all cases under study FNA smears permitted accurate classification<br />

<strong>of</strong> melanoma subtype when compared to the enucleates. Furthermore,<br />

subsequent DNA extraction allowed pyrosequencing with accordance <strong>of</strong> 100%.<br />

Conclusion: We established a reliable, easy to use method on FNA with first,<br />

evaluation <strong>of</strong> the histological subtype and second, subsequent DNA extraction<br />

and testing for monosomy 3.<br />

PO-ONC-13<br />

A CLINICAL AND HISTOPATHOLOGICAL CORRELATION OF EYE LID<br />

TUMORS<br />

Pai Vijaya (1) , Pai Prathvi (1) , Hazarika Manali<br />

1. Dept <strong>of</strong> Ophthalmology,Kasturba Medical College, Manipal University,<br />

OBJECTIVE: A clinical and histopathological correlation <strong>of</strong> eyelid tumours<br />

Methods: A retrospective analysis <strong>of</strong> eyelid tumours between 2000 and 2011 .<br />

Results: 11 patients (7-male, 4-female) were included. Age <strong>of</strong> the patients<br />

varied from 7 to 82 years (Mean-58.9). Duration <strong>of</strong> illness ranged from one<br />

year to 12 years. Clinical diagnosis suspected were basal cell carcinoma-6,<br />

squamous cell carcinoma (SCC)-3, molluscum contagiosum/papilloma-1 and<br />

keratoacanthoma-1. The histopathology <strong>of</strong> tumour correlated with clinical<br />

diagnosis in three patients (i.e., BCC). Other histopathological diagnosis being<br />

SCC-1, malignant melanoma (MM) -1, Seborrhoeic keratoses-1, meibomian<br />

gland carcinoma-1, sebaceous carcinoma-1, cutaneous myxoma-1, ocular<br />

myiasis-1 and sebaceous papilloma-1. Orbital involvement was seen in 2<br />

patients. 2 patients had lymph node involvement . 9 patients underwent wide<br />

mass excision and lid reconstruction and 2 patient underwent exentration (BCC<br />

and Orbital myiasis).Additional radiotherapy was given in 3 patients (BCC-1,<br />

meibomian gland carcinoma-1, sebaceous carcinoma-1). Chemoradiation<br />

was done in one patient (MM). Recurrence noted in 1 patient with SCC during<br />

follow up period.<br />

Conclusion: This study Gives perspective <strong>of</strong> the myriad presentation <strong>of</strong> tumours<br />

<strong>of</strong> the eyelids. Histopathological and clinical correlation was noted in only three<br />

cases. This may be in view <strong>of</strong> the rarity <strong>of</strong> tumours.<br />

PO-ONC-14<br />

Complete cheek basal cell carcinoma remission with imiquimod in a<br />

patient with contralateral lower lid basal cell carcinoma excision<br />

Perez Benjamin (1,2) , Rivera Jorge (1,2) , Navarro Patricia (1,2)<br />

1. Centro Especializado en Oncologia Ocular<br />

2. Centro Ocular Texcoco<br />

Objective/Purpose To report the succesfully treatment <strong>of</strong> basal cell carcinoma<br />

<strong>of</strong> the cheek with topical imiquamod - Methods A 75 year-old female patient<br />

who previously underwent surgical excision <strong>of</strong> basal cell carcinoma <strong>of</strong> the left<br />

lower lid was treated with topical imiquamod four times a day for six weeks<br />

on a right cheek lesion - Results There were complete resolution <strong>of</strong> the cheek<br />

lesion after six weeks <strong>of</strong> topical imiquamod - Conclusion Imiquamod is a good<br />

treatment option for basal cell carcinoma <strong>of</strong> the lid skin and sourrounding areas

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!